PDF(Pubmed)
Abstract：
To describe a case of transient bilateral vitreomacular traction syndrome associated with topical 1% pilocarpine ophthalmic solution in both eyes as a treatment for advanced glaucoma.
UNASSIGNED: Spectral-domain OCT demonstrated bilateral vitreomacular traction syndrome after initiation of topical 1% pilocarpine solution in both eyes for advanced glaucoma. Follow-up imaging revealed the resolution of vitreomacular traction after cessation of the drug without a complete posterior vitreous detachment.
UNASSIGNED: In the advent of new pilocarpine formulations, this case raises the concern of vitreomacular traction syndrome as a serious potential sequela of long-term topical pilocarpine use.
UNASSIGNED: Spectral-domain OCT demonstrated bilateral vitreomacular traction syndrome after initiation of topical 1% pilocarpine solution in both eyes for advanced glaucoma. Follow-up imaging revealed the resolution of vitreomacular traction after cessation of the drug without a complete posterior vitreous detachment.
UNASSIGNED: In the advent of new pilocarpine formulations, this case raises the concern of vitreomacular traction syndrome as a serious potential sequela of long-term topical pilocarpine use.
摘要：
描述一例与双眼局部使用1％毛果芸香碱眼用溶液相关的短暂性双侧玻璃体黄斑牵引综合征，以治疗晚期青光眼。
■谱域OCT在双眼局部应用1%毛果芸香碱溶液治疗晚期青光眼后显示双侧玻璃体黄斑牵引综合征。随访成像显示，停药后玻璃体牵引的分辨率没有完全的后部玻璃体脱离。
■随着新的毛果芸香碱配方的出现，该病例引起了人们对玻璃体黄斑牵引综合征的关注，认为这是长期外用毛果芸香碱的严重潜在后遗症。
■谱域OCT在双眼局部应用1%毛果芸香碱溶液治疗晚期青光眼后显示双侧玻璃体黄斑牵引综合征。随访成像显示，停药后玻璃体牵引的分辨率没有完全的后部玻璃体脱离。
■随着新的毛果芸香碱配方的出现，该病例引起了人们对玻璃体黄斑牵引综合征的关注，认为这是长期外用毛果芸香碱的严重潜在后遗症。
